Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming Lung Yu

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)1023-1025
Number of pages3
JournalClinical and Molecular Hepatology
Volume30
Issue number4
DOIs
StatePublished - Oct 2024

Keywords

  • DAA
  • HCV
  • SVR

Cite this